+1 (704) 266-3234

Global MRNA Vaccines Market Size, Status And Forecast 2021-2027

Published on: Jul 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 96

When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine.

In 2021, the global mRNA Vaccines market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global mRNA Vaccines status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the mRNA Vaccines development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global mRNA Vaccines Scope and Market Size
mRNA Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Being Developed
Preclinical
Clinical I
Clinical II

Segment by Application
COVID-19
Cancer
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
MODERNA
Pfizer
Zydus Cadila
Fosun Pharmaceutical
CureVac
Stemirna

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines Market Size Growth Rate by Type (2021-2027)
1.2.2 Being Developed
1.2.3 Preclinical
1.2.4 Clinical I
1.2.5 Clinical II
1.3 Market by Application
1.3.1 Global mRNA Vaccines Market Share by Application (2021-2027)
1.3.2 COVID-19
1.3.3 Cancer
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global mRNA Vaccines Market Size
2.2 mRNA Vaccines Market Size by Regions
2.2.1 mRNA Vaccines Growth Rate by Regions (2021-2027)
2.2.2 mRNA Vaccines Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 mRNA Vaccines Revenue by Players (2020-2021)
3.2 mRNA Vaccines Key Players Headquaters and Area Served
3.3 Key Players mRNA Vaccines Product/Solution/Service
3.4 Date of Enter into mRNA Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global mRNA Vaccines Market Size by Type (2021-2027)
4.2 Global mRNA Vaccines Market Size by Application (2021-2027)

5 North America
5.1 North America mRNA Vaccines Market Forecast (2021-2027)
5.2 mRNA Vaccines Key Players in North America
5.3 North America mRNA Vaccines Market Size by Type
5.4 North America mRNA Vaccines Market Size by Application
6.4.4 Canada

6 Europe
6.1 Europe mRNA Vaccines Market Forecast (2021-2027)
6.2 mRNA Vaccines Key Players in Europe
6.3 Europe mRNA Vaccines Market Size by Type
6.4 Europe mRNA Vaccines Market Size by Application

7 Japan
7.1 Japan mRNA Vaccines Market Forecast (2021-2027)
7.2 mRNA Vaccines Key Players in Europe
7.3 Japan mRNA Vaccines Market Size by Type
7.4 Japan mRNA Vaccines Market Size by Application

8 Rest of World
8.1 China
8.1.1 China mRNA Vaccines Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia mRNA Vaccines Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India mRNA Vaccines Market Analysis
8.3.2 Key Players in India


9 International Player Profiles
9.1 MODERNA
9.1.1 MODERNA Company Details
9.1.2 MODERNA Description and Business Overview
9.1.3 MODERNA mRNA Vaccines Introduction
9.1.4 MODERNA Revenue in mRNA Vaccines Business (2020-2021)
9.1.5 MODERNA Recent Development
9.2 Pfizer
9.2.1 Pfizer Company Details
9.2.2 Pfizer Description and Business Overview
9.2.3 Pfizer mRNA Vaccines Introduction
9.2.4 Pfizer Revenue in mRNA Vaccines Business (2020-2021)
9.2.5 Pfizer Recent Development
9.3 Zydus Cadila
9.3.1 Zydus Cadila Company Details
9.3.2 Zydus Cadila Description and Business Overview
9.3.3 Zydus Cadila mRNA Vaccines Introduction
9.3.4 Zydus Cadila Revenue in mRNA Vaccines Business (2020-2021)
9.3.5 Zydus Cadila Recent Development
9.4 Fosun Pharmaceutical
9.4.1 Fosun Pharmaceutical Company Details
9.4.2 Fosun Pharmaceutical Description and Business Overview
9.4.3 Fosun Pharmaceutical mRNA Vaccines Introduction
9.4.4 Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2020-2021)
9.4.5 Fosun Pharmaceutical Recent Development
9.5 CureVac
9.5.1 CureVac Company Details
9.5.2 CureVac Description and Business Overview
9.5.3 CureVac mRNA Vaccines Introduction
9.5.4 CureVac Revenue in mRNA Vaccines Business (2020-2021)
9.5.5 CureVac Recent Development
9.6 Stemirna
9.6.1 Stemirna Company Details
9.6.2 Stemirna Description and Business Overview
9.6.3 Stemirna mRNA Vaccines Introduction
9.6.4 Stemirna Revenue in mRNA Vaccines Business (2020-2021)
9.6.5 Stemirna Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global mRNA Vaccines Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Being Developed
Table 3. Key Players of Preclinical
Table 4. Key Players of Clinical I
Table 5. Key Players of Clinical II
Table 6. Global mRNA Vaccines Market Size Growth by Application (2021-2027) (US$ Million)
Table 7. Global mRNA Vaccines Market Size by Regions (2021-2027) (US$ Million)
Table 8. Global mRNA Vaccines Market Share by Regions (2021-2027)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global mRNA Vaccines Revenue by Players (2020-2021) (US$ Million)
Table 12. Global mRNA Vaccines Market Share by Players (2020-2021)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players mRNA Vaccines Product Solution and Service
Table 15. Date of Enter into mRNA Vaccines Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 18. Global mRNA Vaccines Market Size Share by Type (2021-2027)
Table 19. Global mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 20. Global mRNA Vaccines Market Size Share by Application (2021-2027)
Table 21. North America Key Players mRNA Vaccines Revenue (2020-2021) (US$ Million)
Table 22. North America Key Players mRNA Vaccines Market Share (2020-2021)
Table 23. North America mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 24. North America mRNA Vaccines Market Share by Type (2021-2027)
Table 25. North America mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 26. North America mRNA Vaccines Market Share by Application (2021-2027)
Table 27. Europe Key Players mRNA Vaccines Revenue (2020-2021) (US$ Million)
Table 28. Europe Key Players mRNA Vaccines Market Share (2020-2021)
Table 29. Europe mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 30. Europe mRNA Vaccines Market Share by Type (2021-2027)
Table 31. Europe mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 32. Europe mRNA Vaccines Market Share by Application (2021-2027)
Table 33. Japan Key Players mRNA Vaccines Revenue (2020-2021) (US$ Million)
Table 34. Japan Key Players mRNA Vaccines Market Share (2020-2021)
Table 35. Japan mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 36. Japan mRNA Vaccines Market Share by Type (2021-2027)
Table 37. Japan mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 38. Japan mRNA Vaccines Market Share by Application (2021-2027)
Table 39. Key Players in China
Table 40. Key Players in Southeast Asia
Table 41. Key Players in India
Table 42. MODERNA Company Details
Table 43. MODERNA Description and Business Overview
Table 44. MODERNA mRNA Vaccines Product
Table 45. MODERNA Revenue in mRNA Vaccines Business 2020 and 2021
Table 46. MODERNA Recent Development
Table 47. Pfizer Company Details
Table 48. Pfizer Description and Business Overview
Table 49. Pfizer mRNA Vaccines Product
Table 50. Pfizer Revenue in mRNA Vaccines Business 2020 and 2021
Table 51. Pfizer Recent Development
Table 52. Zydus Cadila Company Details
Table 53. Zydus Cadila Description and Business Overview
Table 54. Zydus Cadila mRNA Vaccines Product
Table 55. Zydus Cadila Revenue in mRNA Vaccines Business 2020 and 2021
Table 56. Zydus Cadila Recent Development
Table 57. Fosun Pharmaceutical Company Details
Table 58. Fosun Pharmaceutical Description and Business Overview
Table 59. Fosun Pharmaceutical mRNA Vaccines Product
Table 60. Fosun Pharmaceutical Revenue in mRNA Vaccines Business 2020 and 2021
Table 61. Fosun Pharmaceutical Recent Development
Table 62. CureVac Company Details
Table 63. CureVac Description and Business Overview
Table 64. CureVac mRNA Vaccines Product
Table 65. CureVac Revenue in mRNA Vaccines Business 2020 and 2021
Table 66. CureVac Recent Development
Table 67. Stemirna Company Details
Table 68. Stemirna Description and Business Overview
Table 69. Stemirna mRNA Vaccines Product
Table 70. Stemirna Revenue in mRNA Vaccines Business 2020 and 2021
Table 71. Stemirna Recent Development
Table 72. mRNA Vaccines Market Trends
Table 73. mRNA Vaccines Market Drivers
Table 74. mRNA Vaccines Market Challenges
Table 75. mRNA Vaccines Market Restraints
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccines Market Share by Type in 2021 & 2027
Figure 2. Being Developed Features
Figure 3. Preclinical Features
Figure 4. Clinical I Features
Figure 5. Clinical II Features
Figure 6. Global mRNA Vaccines Market Share by Application in 2021 & 2027
Figure 7. COVID-19 Case Studies
Figure 8. Cancer Case Studies
Figure 9. Infectious Disease Treatment MRNA Vaccine Case Studies
Figure 10. Infection Prevention MRNA Vaccine Case Studies
Figure 11. mRNA Vaccines Report Years Considered
Figure 12. Global mRNA Vaccines Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 13. Global mRNA Vaccines Market Share by Regions (2020-2027)
Figure 14. Global mRNA Vaccines Market Share by Players in 2021
Figure 15. Global mRNA Vaccines Market Size Market Share by Type (2021-2027)
Figure 16. Global mRNA Vaccines Market Size Market Share by Application (2021-2027)
Figure 17. Global mRNA Vaccines Revenue Market Share by Application in 2021
Figure 18. North America mRNA Vaccines Market Size 2021-2027 (US$ Million)
Figure 19. Europe mRNA Vaccines Market Size 2021-2027 (US$ Million)
Figure 20. Japan mRNA Vaccines Market Size 2021-2027 (US$ Million)
Figure 21. mRNA Vaccines Market Size in China (2021-2027) (US$ Million)
Figure 22. mRNA Vaccines Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 23. mRNA Vaccines Market Size in India (2021-2027) (US$ Million)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.